- Tuesday, April 23, 2024
By: Eastern Eye Staff
SCIENTISTS unpicking the gene faults behind an aggressive blood cancer called acute myeloid leukaemia (AML) have found it is not a single disease, but at least 11 different ones with important differences for patients’ likely survival chances. The findings, from the largest study of its kind, could improve clinical trials for testing and developing new AML drugs and change the way patients are diagnosed and treated in future, according to the international team of researchers. “We have shown that AML is an umbrella term for a group of at least 11 different types of leukaemia,” said Peter Campbell, who co-led…
You do not have access to this content. You need to subscribe.
